|
Volumn 72, Issue 1-3, 2001, Pages 133-144
|
Drug permeation enhancement via buccal route: Possibilities and limitations
|
Author keywords
Bile salts; Buccal; Chitosan; Hydrocortisone; Morphine; Penetration enhancement; TGF
|
Indexed keywords
ACETIC ACID;
ALPHA INTERFERON;
ANTIINFLAMMATORY AGENT;
BILE SALT;
BUSERELIN;
CHELATING AGENT;
CHITOSAN;
CYCLODEXTRIN;
FATTY ACID;
FATTY ACID DERIVATIVE;
FLUORESCEIN ISOTHIOCYANATE;
GLUCAGON LIKE PEPTIDE 1;
GONADORELIN;
HYDROCORTISONE;
INSULIN;
LAUROCAPRAM;
MORPHINE;
MORPHINE SULFATE;
OCTREOTIDE;
PENETRATION ENHANCING AGENT;
PEPTIDE;
SURFACTANT;
TRANSFORMING GROWTH FACTOR BETA;
ARTICLE;
CHEEK MUCOSA;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DEGRADATION;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG PENETRATION;
DRUG SAFETY;
FIRST PASS EFFECT;
GASTROINTESTINAL TRACT;
HUMAN;
MOUTH MUCOSA;
NONHUMAN;
PRIORITY JOURNAL;
SYSTEMIC CIRCULATION;
ADMINISTRATION, BUCCAL;
ANIMALS;
EXCIPIENTS;
HUMANS;
PERMEABILITY;
PHARMACEUTICAL PREPARATIONS;
PHARMACOKINETICS;
|
EID: 0035858298
PISSN: 01683659
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-3659(01)00269-3 Document Type: Article |
Times cited : (255)
|
References (42)
|